Back to Agenda
Looking forward to this session? Share it!
- Discuss the evolving nature of US environment leading to an increase in use of Real-World Evidence (RWE)
- Evaluate the role of RWE in Oncology Product Registration in the US
- Identify opportunities in leveraging RWE to support access, reimbursement, and commercialization in the US